Related Experiment Video
Updated: Feb 10, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma
Jin Zhou1, Lipeng Liu1, Tuo Yang1
1Department of Urology, Tianjin Nankai Hospital, Tianjin 300100, P.R. China.
Abstract:
Immune checkpoint blockade therapy (ICBT) uses drugs to interrupt signaling pathways that inhibit antitumor immune responses. Although ICBT has provided clinical benefits in certain cancer patients, a large number of patients do not respond to ICBT. Therefore, it is necessary to find other efficient targets to promote the effects of ICBT. Renal cell carcinoma (RCC) is one of the leading causes of cancer-associated mortality worldwide. To date, there is no efficient treatment for patients with advanced RCC. The present study aimed to evaluate the prognostic value of CD103+ cells in patients with RCC and their potential role in enhancing the effect of ICBT in RCC. A total of 200 tumor tissue samples were collected from patients with RCC. The CD103+ cell count and survival of these patients was assessed, and the role of CD103+ cells in combination with ICBT was evaluated in an RCC mouse model. It was identified that a high CD103+ cell count was an independent favorable prognosticator in patients with RCC. The expansion of CD103+ cells promoted the effects of ICBT in the RCC xenograft mouse model, while depletion of CD103+ cells had the opposite effect. Furthermore, the expansion of CD103+ cells enhanced the count and activation of tumor infiltrating CD8+ T cells in RCC tumor tissue. These results indicate that a high CD103+ cell count is an independent favorable prognosticator in RCC patients. Thus, the expansion of CD103+ cells may increase the efficacy of ICBT in patients with RCC.
Insights
High CD103+ cell counts are a favorable prognostic indicator in renal cell carcinoma (RCC) patients. Expanding these cells may improve the effectiveness of immune checkpoint blockade therapy (ICBT) in treating RCC.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Immune checkpoint blockade therapy (ICBT) shows promise but lacks efficacy in many cancer patients.
- Renal cell carcinoma (RCC) remains a significant cause of cancer mortality with limited treatment options for advanced stages.
Purpose of the Study:
- To investigate the prognostic value of CD103+ cells in RCC.
- To determine if CD103+ cells can enhance the efficacy of ICBT in RCC.
Main Methods:
- Analysis of CD103+ cell counts and survival in 200 RCC patient tumor samples.
- Evaluation of CD103+ cell function in combination with ICBT using an RCC mouse model.
Main Results:
- A high CD103+ cell count was identified as an independent favorable prognostic factor in RCC.
- Expansion of CD103+ cells enhanced ICBT effects in an RCC mouse model, while depletion reduced efficacy.
- CD103+ cell expansion increased the number and activation of tumor-infiltrating CD8+ T cells in RCC.
Conclusions:
- Elevated CD103+ cell counts signify a positive prognosis for RCC patients.
- Strategies to expand CD103+ cells could potentially improve ICBT response rates in RCC treatment.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Therapeutic Index
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...